Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

En bloc resection for nonmuscle invasive bladder cancer: Review of the recent literature

Mori K., D'Andrea D., Enikeev D. V., Egawa S., Shariat Sh.
Current Opinion in Urology
Vol.30, Issue1, P. 41-47
Опубликовано: 2020
Тип ресурса: Обзор

DOI:10.1097/MOU.0000000000000697

Аннотация:
Purpose of reviewConventional transurethral resection of bladder tumor (cTURBT) is the standard approach to the diagnosis and treatment of nonmuscle invasive bladder cancer. However, it suffers from inherent limitations such as insufficient assessment of resection depth and the need for intravesical tumor fragmentation that hampers histopathological evaluation. We summarize recent clinical data on en bloc resection of bladder tumor (ERBT), a method that promises to overcome these limitations.Recent findingsThe PubMed/Medline databases were searched for reports on ERBT focusing on trends in the last 2 years. ERBT provides greater resection quality, making up to 95[%] of detrusor muscle available for pathological evaluation. ERBT also allows detection of the muscularis mucosae thus facilitating T1 substaging. Available data demonstrate no significant difference in perioperative morbidity. No conclusions can be drawn on the impact of either modality on tumor recurrence and progression, as t
Ключевые слова:
conventional transurethral resection of bladder tumor; en bloc resection of bladder tumor; muscularis mucosae; nonmuscle invasive bladder cancer
bladder mucosa; cancer growth; cancer recurrence; cancer surgery; clinical outcome; cystectomy; detrusor muscle; en bloc resection; human; minimal residual disease; morbidity; non muscle invasive bladder cancer; perioperative period; postoperative period; priority journal; Review; surgical margin; bladder tumor; disease exacerbation; pathology; tumor recurrence; urologic surgery; Cystectomy; Disease Progression; Humans; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Urologic Surgical Procedures
Язык текста: Английский
ISSN: 1473-6586
Mori K.
D'Andrea D.
Enikeev D. V. Dmitrij Viktorovich 1982-
Egawa S.
Shariat Sh. Sharokh 1973-
Мори К.
Д'Андреа Д.
Еникеев Д. В. Дмитрий Викторович 1982-
Егаwа С.
Шариат Ш. Шарох 1973-
En bloc resection for nonmuscle invasive bladder cancer: Review of the recent literature
Текст визуальный непосредственный
Current Opinion in Urology
Lippincott Williams & Wilkins
Vol.30, Issue1 P. 41-47
2020
Обзор
conventional transurethral resection of bladder tumor en bloc resection of bladder tumor muscularis mucosae nonmuscle invasive bladder cancer
bladder mucosa cancer growth cancer recurrence cancer surgery clinical outcome cystectomy detrusor muscle en bloc resection human minimal residual disease morbidity non muscle invasive bladder cancer perioperative period postoperative period priority journal Review surgical margin bladder tumor disease exacerbation pathology tumor recurrence urologic surgery Cystectomy Disease Progression Humans Neoplasm Recurrence, Local Urinary Bladder Neoplasms Urologic Surgical Procedures
Purpose of reviewConventional transurethral resection of bladder tumor (cTURBT) is the standard approach to the diagnosis and treatment of nonmuscle invasive bladder cancer. However, it suffers from inherent limitations such as insufficient assessment of resection depth and the need for intravesical tumor fragmentation that hampers histopathological evaluation. We summarize recent clinical data on en bloc resection of bladder tumor (ERBT), a method that promises to overcome these limitations.Recent findingsThe PubMed/Medline databases were searched for reports on ERBT focusing on trends in the last 2 years. ERBT provides greater resection quality, making up to 95[%] of detrusor muscle available for pathological evaluation. ERBT also allows detection of the muscularis mucosae thus facilitating T1 substaging. Available data demonstrate no significant difference in perioperative morbidity. No conclusions can be drawn on the impact of either modality on tumor recurrence and progression, as t